Avalo Therapeutics, Inc. (AVTX) Insider Trading

Over the last 3 months, AVTX insiders made 0 open-market buys and 29 sales, a net sale of -$5.9M (SEC Form 4). Over the last 6 months, 66 institutions increased and 31 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
29
Net (3m)
-$5.9M
Insider trades by month Buys Sells
Nov
Nov
Mar
Apr
May
Jun
Context3-month price +23.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 25, 2026Doyle Mittieofficer: Chief Medical OfficerSell1,450$18.00
Jun 25, 2026Philip Ron MdirectorGrant40,200$17.83
Jun 25, 2026Doyle Mittieofficer: Chief Medical OfficerOption1,450$8.04
Jun 12, 2026Doyle Mittieofficer: Chief Medical OfficerTax1,084$13.10
Jun 12, 2026Riley Jenniferofficer: Chief Strategy OfficerTax588$13.10
Jun 12, 2026VARKI PAULofficer: Chief Legal OfficerTax1,081$13.10
Jun 12, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerTax138$13.10
Jun 4, 2026Lind Kevin RobertdirectorGrant20,100$13.96
Jun 4, 2026KANTOFF AARONdirectorGrant20,100$13.96
Jun 4, 2026Truex SamanthadirectorGrant20,100$13.96
Jun 4, 2026Heffernan Michael ThomasdirectorGrant29,500$13.96
Jun 4, 2026KAPLAN GILLAdirectorGrant20,100$13.96
Jun 4, 2026Jain RitadirectorGrant20,100$13.96
Jun 1, 2026Doyle Mittieofficer: Chief Medical OfficerOption679$8.04
Jun 1, 2026Doyle Mittieofficer: Chief Medical OfficerSell679$16.00
May 26, 2026Doyle Mittieofficer: Chief Medical OfficerGrant43,500
May 26, 2026Riley Jenniferofficer: Chief Strategy OfficerGrant34,200
May 26, 2026NEIL GARRY ARTHURdirector, officer: Chief Executive OfficerGrant100,200
May 26, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerGrant39,900
May 26, 2026VARKI PAULofficer: Chief Legal OfficerGrant24,300
May 19, 2026Doyle Mittieofficer: Chief Medical OfficerOption3,000$12.65
May 19, 2026Doyle Mittieofficer: Chief Medical OfficerSell3,000$18.76
May 11, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerOption18,606$9.88
May 11, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerSell18,606$24.12
May 7, 2026VARKI PAULofficer: Chief Legal OfficerSell5,196$19.78
May 7, 2026Chan MitchelldirectorSell3,167$22.88
May 7, 2026Doyle Mittieofficer: Chief Medical OfficerSell5,000$19.65
May 7, 2026VARKI PAULofficer: Chief Legal OfficerOption12,563$8.04
May 7, 2026VARKI PAULofficer: Chief Legal OfficerSell9,253$22.70
May 7, 2026Doyle Mittieofficer: Chief Medical OfficerSell19,015$22.41

Source: AVTX SEC Form 4 filings, latest Jun 25, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their AVTX positions over the last 6 months (SEC Form 13F).

Increased
66
New positions
70
Reduced
31
Sold out
30
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased2.9MMay 15, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.New Position2.2MMay 15, 2026
CALIGAN PARTNERS LPIncreased1.6MMay 15, 2026
BVF INC/ILIncreased1.6MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.4MMay 15, 2026
AVORO CAPITAL ADVISORS LLCNew Position1.4MMay 15, 2026
BVF INC/ILIncreased1.4MFeb 17, 2026
AFFINITY ASSET ADVISORS, LLCIncreased1.3MMay 14, 2026
LOGOS GLOBAL MANAGEMENT LPNew Position1.3MMay 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged1.2MMay 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged1.2MFeb 13, 2026
ORBIMED ADVISORS LLCReduced1.2MFeb 17, 2026
UBS GROUP AGIncreased1.1MMay 5, 2026
CAPTION MANAGEMENT, LLCIncreased1.1MMay 15, 2026
AFFINITY ASSET ADVISORS, LLCIncreased1.1MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.